A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.
Clinical trial NCT04086823 · COMPLETED
Trial details
- NCT number
- NCT04086823
- Sponsor
- Raziel Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-25
- Primary completion
- 2020-09-16
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.